ISOLATEMS Trademark

Trademark Overview

On Monday, May 1, 2017, a trademark application was filed for ISOLATEMS with the United States Patent and Trademark Office. The USPTO has given the ISOLATEMS trademark a serial number of 87432321. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 25, 2024. This trademark is owned by IQuity Labs, Inc.. The ISOLATEMS trademark is filed in the Medical Instrument Products category with the following description:

Medical diagnostic test kits consisting primarily of blood collection tubes used for nucleic acid isolation for determining the presence or absence of autoimmune and related disorders, namely, multiple sclerosis
isolatems

General Information

Serial Number87432321
Word MarkISOLATEMS
Filing DateMonday, May 1, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 25, 2024
Registration Number5440059
Registration DateTuesday, April 3, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesMedical diagnostic test kits consisting primarily of blood collection tubes used for nucleic acid isolation for determining the presence or absence of autoimmune and related disorders, namely, multiple sclerosis

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 25, 2024
Primary Code010
First Use Anywhere DateMonday, July 31, 2017
First Use In Commerce DateMonday, July 31, 2017

Trademark Owner History

Party NameIQuity Labs, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNashville, TN 37203
Party NameIQuity Labs, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNashville, TN 37203

Trademark Events

Event DateEvent Description
Thursday, May 4, 2017NEW APPLICATION ENTERED
Tuesday, August 8, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, May 5, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 27, 2017ASSIGNED TO EXAMINER
Tuesday, August 8, 2017NON-FINAL ACTION WRITTEN
Tuesday, August 8, 2017NON-FINAL ACTION E-MAILED
Monday, January 29, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 29, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 29, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 30, 2018AMENDMENT TO USE PROCESSING COMPLETE
Thursday, February 1, 2018NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Monday, January 29, 2018TEAS AMENDMENT OF USE RECEIVED
Tuesday, January 30, 2018USE AMENDMENT FILED
Wednesday, January 31, 2018USE AMENDMENT ACCEPTED
Wednesday, January 31, 2018APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Friday, February 16, 2018ASSIGNED TO LIE
Tuesday, April 3, 2018REGISTERED-SUPPLEMENTAL REGISTER
Saturday, August 21, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, August 21, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 26, 2018LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, August 21, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, August 21, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, August 21, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, August 21, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, April 3, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, October 25, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

isolatems absence presence determining isolation autoimmune related sclerosis multiple namely disorders